Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Equity Ratio (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Equity Ratio for 16 consecutive years, with 0.17 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 65.71% to 0.17 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17 through Dec 2025, down 65.71% year-over-year, with the annual reading at 0.17 for FY2025, 65.71% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.17 at Harvard Bioscience, down from 0.18 in the prior quarter.
  • The five-year high for Equity Ratio was 0.53 in Q4 2023, with the low at 0.17 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.44, with a median of 0.5 recorded in 2024.
  • The sharpest move saw Equity Ratio increased 8.58% in 2023, then plummeted 65.71% in 2025.
  • Over 5 years, Equity Ratio stood at 0.51 in 2021, then decreased by 3.29% to 0.5 in 2022, then increased by 7.07% to 0.53 in 2023, then fell by 5.98% to 0.5 in 2024, then tumbled by 65.71% to 0.17 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.17, 0.18, and 0.2 for Q4 2025, Q3 2025, and Q2 2025 respectively.